SLNSW-Update on taxane development: new analogs and new...-TN_cdi_doaj_primary_oai_doaj_org_article_70a143572fc74dc3a360809009cdc6d0

Update on taxane development: new analogs and new formulations

Full title: Update on taxane development: new analogs and new formulations

Author/creator: Yared, Jean A, Tkaczuk, Katherine H R.

Call Numbers:

Record Identifier: TN_cdi_doaj_primary_oai_doaj_org_article_70a143572fc74dc3a360809009cdc6d0

Language: English

Formats: Articles

Publishers: New Zealand: Dove Medical Press Limited

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_70a143572fc74dc3a360809009cdc6d0

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Update on taxane development: new analogs and new formulations

    Record identifier

    TN_cdi_doaj_primary_oai_doaj_org_article_70a143572fc74dc3a360809009cdc6d0

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_70a143572fc74dc3a360809009cdc6d0

    Share

    Update on taxane development: new analogs and new formulations

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_70a143572fc74dc3a360809009cdc6d0

    Update on taxane development: new analogs and new formulations

    Full title

    Update on taxane development: new analogs and new formulations

    Author / Creator

    Yared, Jean A ; Tkaczuk, Katherine H R

    Publisher

    New Zealand: Dove Medical Press Limited

    Journal title

    Drug design, development and therapy, 2012, Vol.6 (default), p.371-384

    Record Identifier

    TN_cdi_doaj_primary_oai_doaj_org_article_70a143572fc74dc3a360809009cdc6d0

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Allergic reactions Analogs Analysis Antimitotic agents Antineoplastic agents Antineoplastic Agents - administration & dosage Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Antineoplastic Agents, Phytogenic - administration & dosage Antineoplastic Agents, Phytogenic - adverse effects Antineoplastic Agents, Phytogenic - therapeutic use Bladder Breast cancer Cancer Care and treatment Cell death Chemotherapy Dilution Drug Approval Drug Design Drug resistance Drugs Epothilones Esophagus Evergreen trees FDA approval Formulations Gastric cancer Head and neck cancer Humans Hypersensitivity Hypodermic needles Lung cancer Mitosis Myelosuppression Neoplasms - drug therapy Neoplasms - pathology Neuropathy new antimicrotubule agents new taxane formulations novel taxanes Organic chemistry Paclitaxel Paclitaxel - administration & dosage Paclitaxel - adverse effects Paclitaxel - therapeutic use Patient outcomes Pharmacology Pine needles Polyoxyethylene sorbitan monooleate Product/Service Evaluations Prostate cancer Reagents Regulatory agencies Review Sarcoma Side effects Solid tumors Solvents Squamous cell carcinoma taxane analogs taxane(s) Taxanes Taxoids - administration & dosage Taxoids - adverse effects Taxoids - therapeutic use Taxol Taxotere Toxicity United States United States Food and Drug Administration Yew

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_doaj_primary_oai_doaj_org_article_70a143572fc74dc3a360809009cdc6d0

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_70a143572fc74dc3a360809009cdc6d0

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections